Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filorexant in Primary Insomnia
NCT01021852Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Nov 2009
- Primary completion
- Feb 2011
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of filorexant in Insomnia, sponsored by Merck & Co.. Started Nov 2009; status: completed.
02
Drugs
filorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT01021852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01021852.